Form 4: Johnson & Johnson Executive Jennifer Taubert Reports Stock Option Exercise and Share Disposal
SEC Filing
EVP Jennifer Taubert of Johnson & Johnson reports exercising stock options and disposing of shares to cover the exercise price and taxes.
Summary
- On February 7, 2025, Jennifer Taubert, EVP of Worldwide Innovative Medicine at Johnson & Johnson, exercised employee stock options for 58,504 shares of common stock at a price of $100.06 per share.
- Immediately following the exercise, Ms. Taubert disposed of 47,436 shares at $153.12 to cover the exercise price and associated taxes.
- After these transactions, Ms. Taubert directly owns 165,919.001 shares of Johnson & Johnson common stock.
Sentiment
Score: 5
Explanation: This is a neutral event; it's a standard transaction related to executive compensation. It doesn't inherently signal positive or negative sentiment about the company's future.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, allowing investors to track executive sentiment and potential alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 02/10/2018 | Original date the Employee Stock Options became exercisable |
| 02/09/2025 | Expiration date of the Employee Stock Options |
| 02/07/2025 | Date of stock option exercise and share disposal |
| 02/11/2025 | Form 4 filing date |
Keywords
Form 4, JNJ, Johnson & Johnson, Stock Options, Jennifer Taubert, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.